Integrated Diagnosis and Treatment of CKD on Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorCapital Medical University

About this trial

Objective: To establish a study cohort and follow up of patients with CKD in our hospital, and evaluate the status of integrated CKD diagnosis and treatment according to guidelines in the real world, as well as the clinical prognosis of patients with different stratification.

Methods: By establishing a cohort of 1000 patients with CKD and conducting long-term follow-up, integrated diagnosis and treatment for CKD was performed, namely: Regular monitoring, control of blood pressure, blood glucose, blood lipid, correction of anemia, minerals - bone metabolic abnormalities, malnutrition, acid and alkali, and electrolyte disorder, diet and exercise, such as the guidance of integrated management, non intrusive, observational studies, prospective cohort were analyzed retrospectively, describe the implementation of the integration of diagnosis and treatment, chronic kidney disease (CKD) Stratified analysis and risk factor analysis were performed for cardiovascular disease and other main endpoint events, so as to objectively reflect the status of integrated treatment of CKD and provide data support for continuous quality improvement of CKD diagnosis and treatment and improvement of clinical prognosis of patients.

Eligibility criteria

Qualifiers

≥18 years old;

Voluntarily signed informed consent;

Patients who are estimated to develop CKD.

Disqualifiers

Age < 18 or ≥100 years;

Unable to comply with the procedures stipulated in this study;

Estimated follow-up time ≤6 months.

Trial design

Treatments tested in this trial

  • Integrated diagnosis and treatment for CKD

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Capital Medical University

Lead sponsor

Peking University

Sponsor institution